MEDICOX Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was KRW 5,553.56 million compared to KRW 4,705.94 million a year ago. Net loss was KRW 5,792.25 million compared to KRW 5,521.72 million a year ago. Basic loss per share from continuing operations was KRW 301 compared to KRW 497 a year ago. Diluted loss per share from continuing operations was KRW 301 compared to KRW 497 a year ago. Basic loss per share was KRW 301 compared to KRW 497 a year ago.
For the six months, sales was KRW 0.00013 million compared to KRW 0.00037 million a year ago. Net loss was KRW 7,434.77 million compared to KRW 6,114.15 million a year ago. Basic loss per share from continuing operations was KRW 388 compared to KRW 615 a year ago. Diluted loss per share from continuing operations was KRW 388 compared to KRW 615 a year ago. Basic loss per share was KRW 388 compared to KRW 615 a year ago.